Meet Stratence Partners in 2026 | Commercial Transformation & Pricing Events

Commercial performance does not come from isolated initiatives. It emerges from how Strategy, Pricing and Commercial Execution operate together as an integrated decision system.

Stratence Partners welcomes David Whitaker as Senior Vice President, Chemical Industry. With 40+ years of global experience, David strengthens Stratence’s leadership in commercial transformation for chemical and fragrance organizations.

SPIE in Chemicals provides a unified commercial ecosystem to regain control over pricing, execution and margin discipline in volatile markets.

Volatility has become structural in the Chemical industry. This article explores how leading players are strengthening pricing governance and commercial execution to protect margins and turn complexity into competitive advantage.

How leading chemical companies are transforming volatility into commercial advantage through pricing excellence, governance and AI-enabled execution.

Meet Stratence Partners in 2026 across 10 key global events where pricing, commercial transformation and AI-driven execution take center stage. Discover where strategy turns into measurable impact.

In an environment of structural volatility and margin pressure, Commercial Excellence — accelerated by AI — is becoming the primary driver of profitability and valuation. This White Paper explores how leading organizations translate strategy into disciplined execution.

Pharma transformations fail when operating models don’t evolve. Learn how Stratence Partners helps organizations embed change through governance, processes, and capability building.

The Scalable Global Operating Model transforms local pricing and commercial successes into repeatable, governed and sustainable global impact across HQ, regions and countries.

Traditional BI explains yesterday. AI-powered commercial intelligence enables better decisions tomorrow. A CEO reflection on why intelligence must become decision-ready.

AI-Enabled Workflows remove friction, accelerate decisions and connect strategy, pricing and execution into one unified process. A core SPIE+AI™ pillar that reduces leakage, strengthens discipline and increases operational speed from day one.

AI is becoming the new Chicxulub for commercial strategy — redefining how revenue is created, priced, delivered and scaled. A reflection from our CEO.

Unified governance is the foundation of SPIE+AI™. Aligning strategy, pricing and commercial decisions ensures consistency, transparency and measurable commercial impact across global teams.

Pharma generates data everywhere, but few companies turn it into actionable intelligence. Discover how Stratence Partners helps transform information into measurable strategic advantage.

SPIE+AI™ is Stratence Partners’ unified ecosystem for AI-powered Strategy, Pricing and Commercial Transformation — delivering measurable EBIT, market share and governance impact.

Pharma companies succeed or fail in execution. Discover how Stratence Partners helps global pharma leaders turn strategic intent into measurable commercial performance through AI-powered transformation.

Pharma strategy must evolve to stay ahead of innovation, regulation, and pricing challenges. Discover how Stratence Partners helps global pharma companies align vision, Market Access, and execution for measurable results.

Recap of Pricing Strategy USA Summit 2023 - Elevate your strategies with Stratence Partners & Fernando Ventureira. Don't miss future insight

"I have collaborated with Stratence Partners to implement multiple, successful and global Pricing and Commercial Transformations with...